Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exome-Wide Analysis Identifies a Rare <i>EXD3</i> Missense Variant Associated With Diabetic Kidney Disease.

Kidney international reportsยท2026
Same author

Diabetes and incident stroke and mediation by microvascular dysfunction: Pooled analysis of three population-based studies.

Diabetes, obesity & metabolismยท2025
Same author

Genetics of C-Peptide and Age at Diagnosis in Type 1 Diabetes.

Diabetesยท2024
Same author

Association of macular pigment optical density with retinal layer thicknesses in eyes with and without manifest primary open-angle glaucoma.

BMJ open ophthalmologyยท2023
Same author

Association of fractal dimension and other retinal vascular network parameters with cognitive performance and neuroimaging biomarkers: The Multi-Ethnic Study of Atherosclerosis (MESA).

Alzheimer's & dementia : the journal of the Alzheimer's Associationยท2023
Same author

OMEGA-3 FATTY ACIDS ARE ASSOCIATED WITH DECREASED PRESENCE AND SEVERITY OF DIABETIC RETINOPATHY: A Combined Analysis of MESA and GOLDR Cohorts.

Retina (Philadelphia, Pa.)ยท2023

Related Experiment Video

Updated: May 19, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Carotid atherosclerosis and 10-year changes in cognitive function.

Wenjun Zhong1, Karen J Cruickshanks, Carla R Schubert

  • 1University of Wisconsin-Madison, 1036 WARF, 610 Walnut Street, WI 53726, USA. zhongwenjun80@gmail.com

Atherosclerosis
|August 3, 2012
PubMed
Summary
This summary is machine-generated.

Carotid intima-media thickness (IMT), a marker of atherosclerosis, is linked to increased cognitive decline risk and poorer executive function over ten years. Plaque buildup showed no significant association with cognitive impairment.

More Related Videos

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Related Experiment Videos

Last Updated: May 19, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
09:36

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

Area of Science:

  • Neurology
  • Cardiovascular Science
  • Gerontology

Background:

  • Carotid atherosclerosis is increasingly implicated in age-related cognitive decline.
  • Understanding the link between vascular health and brain function is crucial for aging populations.

Purpose of the Study:

  • To investigate the association between carotid atherosclerosis markers (IMT and plaque) and cognitive function over a 10-year period.
  • To determine if carotid intima-media thickness (IMT) predicts incident cognitive impairment and cognitive test performance.

Main Methods:

  • Longitudinal study (Epidemiology of Hearing Loss Study) of 1651 participants (mean age 66.8 years).
  • Carotid intima-media thickness (IMT) and plaque measured via ultrasound; cognitive function assessed using Mini-Mental State Examination (MMSE) and additional tests.
  • Cognitive impairment defined as MMSE score <24 or physician-diagnosed dementia.

Main Results:

  • Increased carotid IMT was significantly associated with a higher incidence of cognitive impairment (HR: 1.09 per 0.1 mm increase, p=0.02).
  • Larger IMT correlated with slower performance on the Trail-Making Test-part B (2.3s longer per 0.1 mm increase, p=0.02).
  • Carotid plaque was not significantly associated with cognitive impairment or performance on cognitive tests.

Conclusions:

  • Carotid intima-media thickness (IMT) is a predictor of cognitive impairment and executive function decline over a decade.
  • These findings highlight the importance of vascular health in maintaining cognitive function in older adults.